About Fios Genomics
Fios Genomics is a company based in Edinburgh (United Kingdom) founded in 2011. Fios Genomics has raised $1.27 million across 6 funding rounds from investors including Scottish Enterprise, European Union and Archangels. Fios Genomics offers products and services including Bioinformatics Services, Target Triage, Gene Expression Analysis, Proteomics Data Analysis, and Metabolomics Data Analysis. Fios Genomics operates in a competitive market with competitors including Strand Life Sciences, Novogene Corporation, Rejuvenate Bio, Source BioScience and Macrogen, among others.
- Headquarter Edinburgh, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fios Genomics Limited
- Date of Incorporation 15 Apr, 2008
- Jurisdiction EDINBURGH, SCOTLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.27 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
Scottish Enterprise
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fios Genomics
Fios Genomics offers a comprehensive portfolio of products and services, including Bioinformatics Services, Target Triage, Gene Expression Analysis, Proteomics Data Analysis, and Metabolomics Data Analysis.
Provides analysis of biological data for research and development purposes.
Assists in identifying suitable drug targets for validation and advancement.
Analyzes gene data to support discoveries in various disease applications.
Examines protein data to aid in biomarker and drug development studies.
Processes metabolic data for insights in health and environmental research.
People of Fios Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Fios Genomics
Fios Genomics has successfully raised a total of $1.27M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fios Genomics
Fios Genomics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, European Union and Archangels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and expertise are provided to early-stage Scottish companies.
|
Locked | Locked | Locked | |
|
Early-stage Scottish companies are supported with investment and expertise.
|
Locked | Locked | Locked | |
|
Business development and leadership training programs are offered to companies.
|
Locked | Locked | Locked |
Investor details for Fios Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fios Genomics
Investment portfolio details for Fios Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fios Genomics
Detailed financials for Fios Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fios Genomics Comparisons
Peer comparison for Fios Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fios Genomics
Fios Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Novogene Corporation, Rejuvenate Bio, Source BioScience and Macrogen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Fios Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fios Genomics
Complete news archive for Fios Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fios Genomics
Fios Genomics was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Fios Genomics is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Fios Genomics is a funded company, having raised a total of $1.27M across 6 funding rounds to date.
Fios Genomics was founded in 2011 in Edinburgh, United Kingdom, within the genomics sector. Bioinformatics and genomic data analysis services are provided for platforms such as microarrays and other omics technologies. Core operations involve integrating statistical inference methods with explorative and predictive bioinformatics approaches. These services support data interpretation across various biological datasets, focusing on factual analysis delivery.
Fios Genomics's top competitors include Strand Life Sciences, Novogene Corporation and Source BioScience.
Fios Genomics offers Bioinformatics Services, Target Triage, Gene Expression Analysis, Proteomics Data Analysis, and Metabolomics Data Analysis.
Fios Genomics has 4 investors. Key investors include Scottish Enterprise, European Union, Archangels, and TRICAPITAL Angels.